CWA Asset Management Group’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.44M Buy
63,173
+4,851
+8% +$236K 0.1% 199
2026
Q1
$2.5M Buy
58,322
+10,287
+21% +$442K 0.08% 224
2025
Q4
$2.11M Buy
48,035
+878
+2% +$36.3K 0.08% 218
2025
Q3
$1.95M Buy
47,157
+4,946
+12% +$199K 0.07% 231
2025
Q2
$1.86M Buy
42,211
+5,930
+16% +$237K 0.08% 225
2025
Q1
$1.34M Buy
36,281
+9,080
+33% +$324K 0.06% 245
2024
Q4
$906K Buy
27,201
+4,979
+22% +$162K 0.05% 275
2024
Q3
$577K Buy
+22,222
New +$552K 0.03% 335
2024
Q1
$238K Buy
+10,034
New +$223K 0.01% 475

Other funds holding EXEL

CWA Asset Management Group's EXEL Position: Q2 2026 in Review

CWA Asset Management Group increased its Exelixis (EXEL) stake by 8.3% in Q2 2026, buying an estimated $236K and bringing the position to 63,173 shares worth $3.44M. The position accounts for 0.1% of the portfolio, ranked #199.

CWA Asset Management Group first reported a position in EXEL in Q1 2024 and has held it in 9 quarters since. 125 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • CWA Asset Management Group held 63,173 shares of Exelixis worth $3.44M as of Q2 2026.
  • CWA Asset Management Group bought 4,851 Exelixis shares in Q2 2026, an estimated $236K.
  • Exelixis made up 0.1% of CWA Asset Management Group's portfolio in Q2 2026, its #199 holding.
  • CWA Asset Management Group first reported a position in Exelixis in Q1 2024 and has held it in 9 quarters since.
  • 125 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.